Amicus Therapeutics Stock Sees Improved Relative Strength Rating Amicus Therapeutics Stock Sees Improved Relative Strength Rating · Investor's Business Daily INVESTOR'S BUSINESS DAILY and JULIE MAK February 9, 2024 1 min read FOLD Amicus Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating Continue Reading Terms and Privacy Policy Privacy Dashboard More Info